A detailed history of Hrt Financial LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hrt Financial LP holds 123,509 shares of VRTX stock, worth $62.1 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
123,509
Holding current value
$62.1 Million
% of portfolio
0.34%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $48.5 Million - $60 Million
123,509 New
123,509 $57.9 Million
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $1.85 Million - $2.22 Million
5,406 Added 212.67%
7,948 $3.23 Million
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $430,164 - $461,049
-1,272 Reduced 33.35%
2,542 $883,000
Q2 2023

Aug 11, 2023

BUY
$314.42 - $351.91 $1.2 Million - $1.34 Million
3,814 New
3,814 $1.34 Million
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $14.1 Million - $16.6 Million
-63,603 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $11.3 Million - $14.2 Million
63,603 New
63,603 $14 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $1.24 Million - $1.39 Million
-6,834 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$187.49 - $221.1 $4.77 Million - $5.63 Million
-25,442 Reduced 78.83%
6,834 $1.38 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $6.68 Million - $7.79 Million
32,276 New
32,276 $6.94 Million
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $1.53 Million - $2.06 Million
-9,191 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$166.23 - $187.09 $1.53 Million - $1.72 Million
9,191 New
9,191 $1.56 Million
Q2 2019

Aug 14, 2019

SELL
$164.61 - $190.37 $1.28 Million - $1.48 Million
-7,768 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$163.73 - $194.7 $392,952 - $467,280
2,400 Added 44.71%
7,768 $1.43 Million
Q2 2018

Aug 15, 2018

BUY
$145.72 - $169.96 $501,713 - $585,172
3,443 Added 178.86%
5,368 $912,000
Q1 2018

May 14, 2018

BUY
$151.6 - $177.13 $291,830 - $340,975
1,925 New
1,925 $313,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.